Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights Biotech Investing
Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer Biotech Investing
Merck's KEYTRUDA® Significantly Prolonged Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy for Patients With Stage II Resected High-Risk Melanoma in Phase 3 KEYNOTE-716 Trial Pharmaceutical Investing
JAMA Dermatology Publishes Data Showing RINVOQ® Achieved Superiority Versus DUPIXENT® for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis Biotech Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Inc. Investigation Medical Device Investing
BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland Biotech Investing
Health Canada Approves ARAZLO Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris Medical Device Investing
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata Pharmaceutical Investing
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC Medical Device Investing
